TotalMarketCap

Puma Biotechnology

PBYINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$505.360 M

$9.79 -8.42%

Close of 6 Nov 2026

As of 6 Nov 2026, Puma Biotechnology (PBYI) has a market capitalization of $505.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$228.4M

#2233 by revenue

Earnings

$31.1M

#1725 by earnings

Shares outstanding

51,620,066

Latest filing cover page

P/E ratio

16.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #185Climb BioCLYM$510.0M
  2. #186Faeth TherapeuticsFTH$509.9M
  3. #187Puma BiotechnologyPBYI$505.4M
  4. #188Ovid TherapeuticsOVID$503.9M
  5. #189Capricor TherapeuticsCAPR$499.4M

What if Puma Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$547,013.52

Per share 55,875× higher

Bitcoin $1.53T

$29,597.95

Per share 3,023× higher

Apple $5.02T

$97,167.30

Per share 9,925× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Puma Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.